Suppr超能文献

接种疫苗对急性 COVID-19 后患者血小板线粒体生物能量功能的影响。

Effect of Vaccination on Platelet Mitochondrial Bioenergy Function of Patients with Post-Acute COVID-19.

机构信息

Pharmacobiochemical Laboratory of 3rd Medical Department, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia.

Centro Andaluz de Biologia del Desarrollo, Instituto de Salud Carlos III, Universidad Pablo de Olavide-CSIC-3A and CIBERER, 41013 Seville, Spain.

出版信息

Viruses. 2023 Apr 28;15(5):1085. doi: 10.3390/v15051085.

Abstract

BACKGROUND

Mitochondrial dysfunction and redox cellular imbalance indicate crucial function in COVID-19 pathogenesis. Since 11 March 2020, a global pandemic, health crisis and economic disruption has been caused by SARS-CoV-2 virus. Vaccination is considered one of the most effective strategies for preventing viral infection. We tested the hypothesis that preventive vaccination affects the reduced bioenergetics of platelet mitochondria and the biosynthesis of endogenous coenzyme Q (CoQ) in patients with post-acute COVID-19.

MATERIAL AND METHODS

10 vaccinated patients with post-acute COVID-19 (V + PAC19) and 10 unvaccinated patients with post-acute COVID-19 (PAC19) were included in the study. The control group (C) consisted of 16 healthy volunteers. Platelet mitochondrial bioenergy function was determined with HRR method. CoQ, γ-tocopherol, α-tocopherol and β-carotene were determined by HPLC, TBARS (thiobarbituric acid reactive substances) were determined spectrophotometrically.

RESULTS

Vaccination protected platelet mitochondrial bioenergy function but not endogenous CoQ levels, in patients with post-acute COVID-19.

CONCLUSIONS

Vaccination against SARS-CoV-2 virus infection prevented the reduction of platelet mitochondrial respiration and energy production. The mechanism of suppression of CoQ levels by SARS-CoV-2 virus is not fully known. Methods for the determination of CoQ and HRR can be used for monitoring of mitochondrial bioenergetics and targeted therapy of patients with post-acute COVID-19.

摘要

背景

线粒体功能障碍和氧化还原细胞失衡表明其在 COVID-19 发病机制中具有重要作用。自 2020 年 3 月 11 日以来,SARS-CoV-2 病毒引发了全球大流行、健康危机和经济混乱。疫苗接种被认为是预防病毒感染最有效的策略之一。我们检验了以下假设,即预防性疫苗接种是否会影响急性 COVID-19 后患者血小板线粒体的生物能量降低和内源性辅酶 Q(CoQ)的生物合成。

材料和方法

本研究纳入了 10 名接种疫苗的急性 COVID-19 后患者(V+PAC19)和 10 名未接种疫苗的急性 COVID-19 后患者(PAC19)。对照组(C)由 16 名健康志愿者组成。采用 HRR 法测定血小板线粒体生物能量功能。采用 HPLC 测定 CoQ、γ-生育酚、α-生育酚和β-胡萝卜素,采用分光光度法测定 TBARS(硫代巴比妥酸反应物质)。

结果

疫苗接种可保护急性 COVID-19 后患者的血小板线粒体生物能量功能,但不能保护内源性 CoQ 水平。

结论

接种 SARS-CoV-2 病毒疫苗可预防血小板线粒体呼吸和能量产生减少。SARS-CoV-2 病毒降低 CoQ 水平的机制尚不完全清楚。CoQ 和 HRR 的测定方法可用于监测急性 COVID-19 后患者的线粒体生物能量,并对其进行靶向治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730b/10223181/f39ac3a13be9/viruses-15-01085-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验